CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Oct. 27, 2012	Oct. 27, 2011
Net income	$ 5,855	$ 6,736
Depreciation and amortization	4,909	4,773
Deferred taxes	(1,665)	(960)
Provision to value inventories at LIFO	150	360
Non-cash share-based compensation	808	797
Change in merchandise inventories	2,075	(1,670)
Change in patronage dividend receivable	(3,972)	(3,362)
Change in accounts payable to Wakefern	(725)	(2,227)
Change in accounts payable and accrued expenses	(3,997)	(601)
Change in income taxes payable	5,788	3,265
Change in other assets and liabilities	(1,203)	(1,322)
Net cash provided by operating activities	8,023	5,789
Capital expenditures	(5,792)	(6,257)
Investment in notes receivable from Wakefern	(369)	(344)
Net cash used in investing activities	(6,161)	(6,601)
Proceeds from exercise of stock options	131	11
Excess tax benefit related to share-based compensation	52	5
Principal payments of long-term debt	(159)	(100)
Dividends	(2,990)	(1,145)
Net cash used in financing activities	(2,966)	(1,229)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(1,104)	(2,041)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	103,103	91,362
CASH AND CASH EQUIVALENTS, END OF PERIOD	101,999	89,321
Cash payments for interest	995	1,184
Cash payments for income taxes	50	2,597
Non-cash investment in Wakefern	$ 949	$ 269